Skip to main content

Month: May 2020

CreditRiskMonitor 1Q Results

Valley Cottage, NY, May 12, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — CreditRiskMonitor (OTCQX: CRMZ) reported that revenues for the 3 months ended March 31, 2020 increased 6% to $3.71 million compared to $3.50 million in last year’s first quarter. Net loss for the quarter was approximately $198,300 compared to a net loss of approximately $136,500 in the prior year period. Cash and cash equivalents increased approximately $22,500 since 2019 year-end, to $8.30 million, and were down $91,700 from the balance at March 31, 2019. Jerry Flum, CEO, said, “Our net loss increased despite growing sales as the Company continues to invest in an enhanced infrastructure and additional content, which is in addition to strengthening our customer service staff. These strategic investments adversely impact our short-term profits; however,...

Continue reading

NXT Energy Solutions Announces Release Date for Its First Quarter 2020 Results and Conference Call

CALGARY, Alberta, May 12, 2020 (GLOBE NEWSWIRE) — NXT Energy Solutions Inc. (“NXT” or the “Company”) (TSX:SFD; OTC QB:NSFDF) announces it will release its first quarter 2020 financial and operating results for the quarter ended March 31, 2020, on Thursday, May 14, 2020 after market close.  A conference call to discuss the first quarter 2020 results will be held on Tuesday, May 19, 2020 at 4:30 p.m. Eastern Time (2:30 p.m. Mountain Time).  Details of the conference call are as follows:NXT’s first quarter 2020 financial and operating results will be filed in Canada on SEDAR at www.sedar.com and will be available in the USA on EDGAR at www.sec.gov/edgar.  The financial and operating results will also available on NXT’s website at www.nxtenergy.com.About NXT Energy Solutions Inc.NXT Energy Solutions Inc. is a Calgary-based...

Continue reading

Cyber Security 1 AB: The Stockholm District Court Approves CYBER1’S Application For Corporate Restructuring

The Stockholm District Court Approves CYBER1’S Application For Corporate RestructuringLondon United Kingdom – 12 May 2020 – Cyber Security 1 AB (Publ) (the “Company”) (“CYBER1”) (Nasdaq First North: CYB1) confirms that it has today received approval of its application for corporate restructuring.The business operations of the Cyber1 subsidiary companies remain unaffected by the corporate restructuring process.Lawyer David Rutegard, Law Firm Carler, has been appointed Administrator of the proceedings. The creditors’ meeting is scheduled for 1st June 2020 at 14:00 at the Stockholm District Court.This information is information that CYBER1 is obliged to make public, pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below, on 12th May 2020 at 13:15...

Continue reading

SouthGobi announces delay of filings and application for a management cease trade order

VANCOUVER, British Columbia, May 12, 2020 (GLOBE NEWSWIRE) — SouthGobi Resources Ltd. (TSX: SGQ, HK: 1878) (“SouthGobi” or the “Company”) announces that it has been advised by its external auditors (the “Auditors”) that they will not be in a position to render an unmodified opinion on the Company’s annual consolidated financial statements for the year ended December 31, 2019 (the “2019 Financial Statements”) prior to the extended filing deadline of May 14, 2020 (the “Annual Filing Deadline”) because they have not been able to obtain sufficient evidence to support management’s going concern assumptions. As a result, the Company will not be able to file: (i) the 2019 Financial Statements, accompanying Management Discussion & Analysis and the Annual Information Form (collectively, the “2019 Annual Filings”) prior to the Annual...

Continue reading

Lumega-Z® Demonstrates Superiority in a Head-to-Head Study Showing Better Bioavailability of Carotenoids and Restoring Macular Pigment Density

— First study to provide a head-to-head comparison of two commercially available supplements with regard to the changes in serum levels of carotenoids, visual function and macular pigment optical density (MPOD)— Results demonstrated that higher concentration of carotenoids translates to a greater elevation of carotenoids in the target tissues in a healthy population— Lumega-Z supplementation provides approximately 3–4-fold higher absorption than standard AREDS 2 formulation, which leads to a significant elevation and restoration of MPOD levels— Further scientific validation of Lumega-Z with clinical data published in top tier, peer-reviewed journal, NutrientsSan Diego, California, May 12, 2020 (GLOBE NEWSWIRE) — Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), a company that (i)...

Continue reading

Kraig Biocraft Laboratories Prepares for 2020 Production

ANN ARBOR, Mich., May 12, 2020 (GLOBE NEWSWIRE) — Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company”) announces that Company is preparing to transfer production back to Prodigy Textiles, its Vietnamese subsidiary.  During the COVID-19 lockdown, when the Company opted to furlough its non-essential staff, the Company shifted its spider silk production operations focus to its US research facility.  The Company is now ready to transition the majority of its production back to Vietnam as soon as the silkworm rearing cycle allows.During this pandemic, the Company has continued to advance and strengthen its production operations.  Through vigorous testing of its Dragon SilkTM and Monster Silk® lines, the Company identified its best performing and hardy silkworms ideally suited for large scale production. This milestone is the...

Continue reading

Helius Medical Technologies, Inc. Announces FDA Has Granted the PoNS Device Breakthrough Device Designation for the Treatment of Gait Deficits Due to Symptoms of Multiple Sclerosis

NEWTOWN, Pa., May 12, 2020 (GLOBE NEWSWIRE) — Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced that it has received Breakthrough Designation for its PoNS™ device as a potential treatment for gait deficit due to symptoms of Multiple Sclerosis (“MS”), to be used as an adjunct to a supervised therapeutic exercise program.“We are extremely pleased to receive this designation for our PoNS device,” said Philippe Deschamps, the Company’s CEO. “We look forward to working with FDA to process our application, with the ultimate goal of bringing our innovative technology to the aid of patients suffering with gait deficit due to MS-related symptoms, by providing them with a non-drug, non-implantable treatment that has the potential to...

Continue reading

FLYHT Receives Government Loan and Subsidy Funds

CALGARY, Alberta, May 12, 2020 (GLOBE NEWSWIRE) — FLYHT Aerospace Solutions Ltd. (TSX-V: FLY) (OTCQX: FLYLF) (the “Company” or “FLYHT”) today reported that it has received funds under two programs, each designed to support Canadian and American small businesses in keeping their workforces employed during the COVID-19 crisis.Canadian Emergency Wage Subsidy (“CEWS”) program funds totaling $167,589 were received for Period 1, covering March 15 to April 11, 2020. This program automatically qualifies participating companies for one subsequent period, so FLYHT expects to receive a similar subsidy for Period 2, covering April 12 to May 9, 2020. FLYHT will also apply for future funding under this program, if eligibility criteria for subsequent periods are met. This subsidy does not have to be repaid.FLYHT Inc., the Company’s wholly owned...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.